Search
for

    Glossary Golimumab

    medication that inhibits TNF-alpha to treat autoimmune diseases

    Golimumab is a medication used to treat autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in inflammation and immune system responses. This helps reduce symptoms and prevent joint damage in affected individuals.

    Research 9 of 44

    1. First two cases of alopecia areata during golimumab therapy Joint bone spine · 2015 · 1 citations
    2. Interventions for nail psoriasis Cochrane library · 2013 · 65 citations
    3. Repigmentation of hair following adalimumab therapy Dermatology online journal · 2015 · 17 citations
    4. An adult case of suspected A20 haploinsufficiency mimicking polyarteritis nodosa Lara D. Veeken · 2022 · 5 citations
    5. Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition Journal of Dermatological Treatment · 2026 · 1 citations
    6. P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy Rheumatology advances in practice · 2023 · 1 citations
    7. CASE REPORT: BIOLOGICAL THERAPY ASSOCIATION, CASE REPORT OF A PATIENT WITH ANKYLOSING SPONDYLITIS AND ALOPECIA AREATA 2024
    8. Adverse Effects and Drug Interactions of Biologic Agents Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2010
    9. From the Cochrane Library: Interventions for Nail Psoriasis Dermatology · 2025
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →